Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
暂无分享,去创建一个
Edwin Cuppen | Christine Klein | Dagmar Verbaan | Daniela Berg | Thomas Gasser | Peter Heutink | Robin Lemmens | Wim Robberecht | Claudia Schulte | Ewout J. N. Groen | Nicola Ticozzi | Vincenzo Silani | Caroline Dahlberg | Hans Scheffer | R. Ophoff | Robert H. Brown | P. D. de Bakker | B. Bloem | E. Cuppen | R. Folkerth | P. Andersen | A. Birve | H. Blauw | F. Diekstra | J. Landers | W. Robberecht | P. van Damme | L. H. van den Berg | M. V. van Es | P. V. van Vught | J. Veldink | D. Berg | G. Hu | C. Mariani | J. J. van Hilten | P. Heutink | H. J. Schelhaas | T. Gasser | A. Ludolph | D. Verbaan | H. Scheffer | C. Schulte | P. Keagle | C. Klein | Markus Weber | W. van Rheenen | N. Ticozzi | V. Silani | R. Fernández-Santiago | C. Dahlberg | R. Pasterkamp | M. Koppers | K. Fumoto | S. Goldwurm | Wenhao Yu | G. Pezzoli | R. Lemmens | A. J. van der Kooi | M. de Visser | Stefano Goldwurm | Claudio Mariani | Bastiaan R. Bloem | E. Hennekam | Gianni Pezzoli | Marianne de Visser | Markus Weber | Marka van Blitterswijk | S. Waibel | A. L. Leclerc | Philip Van Damme | M. van Blitterswijk | Guo-fu Hu | Robert H. Brown | Helenius J. Schelhaas | Anna Birve | Albert C. Ludolph | Paul I. W. de Bakker | Anne-Marie Wills | H. Kishikawa | Michael A. van Es | Paul W. J. van Vught | Peter M. Andersen | Ewout J. N. Groen | Hylke M. Blauw | Max Koppers | Frank P. Diekstra | Katsumi Fumoto | Ashley Lyn LeClerc | Pamela Keagle | Bart F. L. van Nuenen | Wouter van Rheenen | Patrick P. Lowe | Wenhao Yu | Hiroko Kishikawa | David Wu | Rebecca D. Folkerth | Rubén Fernández-Santiago | Stefan Waibel | Anneke J. van der Kooi | Jacobus J. van Hilten | Eric A. M. Hennekam | Roel A. Ophoff | Jan H. Veldink | R. Jeroen Pasterkamp | John E. Landers | Bart P. van de Warrenburg | Leonard H. van den Berg | David Wu | P. Lowe | B. V. van Nuenen | A. Wills | B. V. D. van de Warrenburg | R. J. Pasterkamp | Robert H. Brown | Pamela J. Keagle
[1] B. Oostra,et al. Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson’s disease in Sardinia , 2011, neurogenetics.
[2] B. Miller,et al. Ataxin-2 repeat-length variation and neurodegeneration. , 2011, Human molecular genetics.
[3] D. Standaert,et al. A neuroprotective role for angiogenin in models of Parkinson’s disease , 2011, Journal of neurochemistry.
[4] Patrizia Sola,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.
[5] V. Bansal,et al. Statistical analysis strategies for association studies involving rare variants , 2010, Nature Reviews Genetics.
[6] A. Al-Chalabi,et al. An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[7] P. Kaňovský,et al. Coexistence of parkinsonism, dementia and upper motor neuron syndrome in four Czech patients , 2010, Journal of the Neurological Sciences.
[8] S. Fahn,et al. Parkinsonism and motor neuron diseases: Twenty‐seven patients with diverse overlap syndromes , 2010, Movement disorders : official journal of the Movement Disorder Society.
[9] Robert H. Brown,et al. Paraoxonase gene mutations in amyotrophic lateral sclerosis , 2010, Annals of neurology.
[10] Takeo Kato,et al. Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.
[11] J. Shulman,et al. Evidence for a common pathway linking neurodegenerative diseases , 2009, Nature Genetics.
[12] G. Rouleau,et al. Genetics of motor neuron disorders: new insights into pathogenic mechanisms , 2009, Nature Reviews Genetics.
[13] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[14] Ewout J N Groen,et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.
[15] C. Duyckaerts,et al. Accumulation of TDP-43 and α-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation , 2009, Acta Neuropathologica.
[16] J. Prehn,et al. Angiogenin protects motoneurons against hypoxic injury , 2009, Cell Death and Differentiation.
[17] Sonja W. Scholz,et al. SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.
[18] T. Illig,et al. Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis , 2009, Journal of Neurology.
[19] S. Browning,et al. A Groupwise Association Test for Rare Mutations Using a Weighted Sum Statistic , 2009, PLoS genetics.
[20] R. Ophoff,et al. A CASE OF ALS-FTD IN A LARGE FALS PEDIGREE WITH A K17I ANG MUTATION , 2009, Neurology.
[21] O. Hardiman,et al. Control of Motoneuron Survival by Angiogenin , 2008, The Journal of Neuroscience.
[22] Peter Donnelly,et al. Progress and challenges in genome-wide association studies in humans , 2008, Nature.
[23] V. Meininger,et al. Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis. , 2008, Archives of neurology.
[24] G. Comi,et al. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the −2578AA genotype , 2008, Journal of Medical Genetics.
[25] A. Kakita,et al. TDP‐43 mutation in familial amyotrophic lateral sclerosis , 2008, Annals of neurology.
[26] B. Hyman,et al. Transcriptional dysregulation in a transgenic model of Parkinson disease , 2008, Neurobiology of Disease.
[27] N. Bresolin,et al. Absence of angiogenic genes modification in Italian ALS patients , 2008, Neurobiology of Aging.
[28] B. Castellotti,et al. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis , 2008, Neurogenetics.
[29] A. Tessitore,et al. A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy , 2008, Neuromuscular Disorders.
[30] E. Beghi,et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[31] A. Iafrate,et al. Angiogenin loss‐of‐function mutations in amyotrophic lateral sclerosis , 2007, Annals of neurology.
[32] B. Traynor,et al. Genetics of sporadic amyotrophic lateral sclerosis. , 2007, Human molecular genetics.
[33] K. Acharya,et al. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. , 2007, Human molecular genetics.
[34] J. Nutt,et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease , 2007, Annals of neurology.
[35] F. Giannini,et al. Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population , 2007, Journal of the Neurological Sciences.
[36] Ying Feng,et al. A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis. , 2007, Human molecular genetics.
[37] S. Ennis,et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.
[38] P. Ragonese,et al. DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex , 2005, Annals of neurology.
[39] S. Ennis,et al. A novel candidate region for ALS on chromosome 14q11.2 , 2004, Neurology.
[40] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[41] J. Nutt,et al. SCA2 may present as levodopa‐responsive parkinsonism , 2003, Movement disorders : official journal of the Movement Disorder Society.
[42] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[43] R. Uitti,et al. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. , 1997, Parkinsonism & related disorders.
[44] W. Johnson,et al. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease , 1994, Neurology.
[45] V. Meininger,et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.
[46] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[47] J. Stockman. Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .
[48] Shamil R Sunyaev,et al. Pooled association tests for rare variants in exon-resequencing studies. , 2010, American journal of human genetics.
[49] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.
[50] P. Carmeliet,et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.
[51] Till Acker,et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.